NCT06118463
Study on AUNIP as a Novel Tumor Marker for Cervical Cancer
Lin Yuan·ClinicalTrials.gov·diagnostic testNot yet recruiting
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Cervical Cancer
- Drug/Device/Intervention
- Detection of serum AUNIP expression
- Study type
- Observational
- Intervention type
- diagnostic test
Sponsor & location
- Primary sponsor
- Lin Yuan
- Funder
- Qianfoshan Hospital
Timeline & enrollment
- Phase
- N/A
- Start date
- Jan 01, 2024
- End date
- Jan 01, 2029
- Enrollment
- 300 participants
Primary outcome
AUNIP expression in serum
Summary
To detect the expression of AUNIP in cervical cancer serum, and to clarify its diagnostic and
 prognostic value.
ICD-10 classifications
Severe cervical dysplasia, not elsewhere classifiedMild cervical dysplasiaModerate cervical dysplasiaCarcinoma in situ: Cervix, unspecifiedCervical root disorders, not elsewhere classified
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06118463
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT06118463 through Pure Global AI's free database. This phase not specified trial is sponsored by Lin Yuan and is currently Not yet recruiting. The study focuses on Cervical Cancer. Target enrollment is 300 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.